{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T04:08:33Z","timestamp":1648699713507},"publisher-location":"Chichester, UK","reference-count":29,"publisher":"John Wiley & Sons, Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/9780470720912.ch5","type":"book-chapter","created":{"date-parts":[[2008,5,30]],"date-time":"2008-05-30T12:54:23Z","timestamp":1212152063000},"page":"55-68","source":"Crossref","is-referenced-by-count":1,"title":["Benefits, Risks and Costs of Immunization Programmes"],"prefix":"10.1002","author":[{"given":"Jeffrey P.","family":"Koplan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,5,30]]},"reference":[{"key":"10.1002\/9780470720912.ch5-BIB1|cit1","first-page":"1","article-title":"Cost-benefits of measles eradication: effects of a Federal intervention","volume":"4","author":"Albritton","year":"1978","journal-title":"Policy Analysis"},{"key":"10.1002\/9780470720912.ch5-BIB2|cit2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2307\/4593651","article-title":"Benefits due to immunization against measles","volume":"84","author":"Axnick","year":"1969","journal-title":"Public Health Rep"},{"key":"10.1002\/9780470720912.ch5-BIB3|cit3","first-page":"339","article-title":"Public Health Service recommendation on smallpox vaccination, and vaccination against smallpox in the United States; a reevaluation of the risks and benefits","volume":"20","author":"Centers for Disease Control","year":"1971","journal-title":"Morbidity Mortality Weekly Rep"},{"key":"10.1002\/9780470720912.ch5-BIB4|cit4","first-page":"317","article-title":"Inactivated hepatitis B virus vaccine","volume":"31","author":"Centers for Disease Control","year":"1982","journal-title":"Morbidity Mortality Weekly Rep"},{"key":"10.1002\/9780470720912.ch5-BIB5|cit5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2307\/3342106","article-title":"Budgetary medical ethics","volume":"4","author":"Foege","year":"1983","journal-title":"J Public Health Policy"},{"key":"10.1002\/9780470720912.ch5-BIB6|cit6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/1523-1747.ep12676614","article-title":"Fiscal returns of biomedical research","volume":"61","author":"Fudenberg","year":"1973","journal-title":"J Invest Dermatol"},{"key":"10.1002\/9780470720912.ch5-BIB7|cit7","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1001\/jama.1984.03340470035022","article-title":"Pertussis and pertussis vaccine-re-analysis of benefits, risks, and costs","volume":"251","author":"Hinman","year":"1984","journal-title":"JAMA (J Am Med Assoc)"},{"key":"10.1002\/9780470720912.ch5-BIB8|cit8","volume-title":"The whooping cough epidemic 1977-1979","author":"Joint Committee on Vaccination and Immunization","year":"1981"},{"key":"10.1002\/9780470720912.ch5-BIB9|cit9","first-page":"255","volume-title":"Influenza: virus, vaccines and strategy","author":"Klarman","year":"1976"},{"key":"10.1002\/9780470720912.ch5-BIB10|cit10","first-page":"362","article-title":"A benefit-cost analysis of mumps vaccine","volume":"136","author":"Koplan","year":"1982","journal-title":"Am J Dis Child"},{"key":"10.1002\/9780470720912.ch5-BIB11|cit11","volume-title":"An update on the benefits and costs of measles and rubella immunization","author":"Koplan","year":"1984"},{"key":"10.1002\/9780470720912.ch5-BIB12|cit12","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJM197910253011703","article-title":"Pertussis vaccine-an analysis of benefits, risks and costs","volume":"301","author":"Koplan","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1002\/9780470720912.ch5-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJM196911272812201","article-title":"Complications of smallpox vaccination, 1968. National surveillance in the United States","volume":"281","author":"Lane","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1002\/9780470720912.ch5-BIB14|cit14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/infdis\/122.4.303","article-title":"Complications of smallpox vaccination, 1968. II. Results of ten statewide surveys","volume":"122","author":"Lane","year":"1970a","journal-title":"J Infect Dis"},{"key":"10.1002\/9780470720912.ch5-BIB15|cit15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jama.1970.03170160031005","article-title":"Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968","volume":"212","author":"Lane","year":"1970b","journal-title":"JAMA (J Am Med Assoc)"},{"key":"10.1002\/9780470720912.ch5-BIB16|cit16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJM198209093071103","article-title":"Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis","volume":"307","author":"Mulley","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1002\/9780470720912.ch5-BIB17|cit17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJM196701192760301","article-title":"Complications of smallpox vaccination. I. National survey in the United States, 1963","volume":"276","author":"Neff","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1002\/9780470720912.ch5-BIB18|cit18","volume-title":"The implications of cost-effectiveness analysis of medical technology","author":"Office of Technology Assessment, US Congress","year":"1980"},{"key":"10.1002\/9780470720912.ch5-BIB19|cit19","volume-title":"Cost-effectiveness of influenza vaccination","author":"Office of Technology Assessment, US Congress","year":"1981"},{"key":"10.1002\/9780470720912.ch5-BIB20|cit20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/jama.1981.03310300027014","article-title":"A cost-benefit analysis of immunization for pneumococcal pneumonia","volume":"245","author":"Patrick","year":"1981","journal-title":"JAMA (J Am Med Assoc)"},{"key":"10.1002\/9780470720912.ch5-BIB21|cit21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1056\/NEJM197602052940604","article-title":"Benefit-cost analysis of rubella vaccination policy","volume":"294","author":"Schoenbaum","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1002\/9780470720912.ch5-BIB22|cit22","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM197609302951405","article-title":"The swine-influenza decision","volume":"295","author":"Schoenbaum","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1002\/9780470720912.ch5-BIB23|cit23","first-page":"37","volume-title":"Cost benefit analysis","author":"Sencer","year":"1973"},{"key":"10.1002\/9780470720912.ch5-BIB24|cit24","first-page":"535","article-title":"First principles of cost-effectiveness analysis in health","volume":"94","author":"Shepard","year":"1979","journal-title":"Public Health Rep"},{"key":"10.1002\/9780470720912.ch5-BIB25|cit25","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJM197703312961304","article-title":"Foundations of cost-effectiveness analysis for health and medical practices","volume":"296","author":"Weinstein","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1002\/9780470720912.ch5-BIB26|cit26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1086\/259766","article-title":"Costs and benefits of medical research: a case study of poliomyelitis","volume":"79","author":"Weisbrod","year":"1971","journal-title":"J Political Economy"},{"key":"10.1002\/9780470720912.ch5-BIB27|cit27","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJM198009043031004","article-title":"Cost effectiveness of vaccination against pneumococcal pneumonia","volume":"303","author":"Willems","year":"1980","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1002\/9780470720912.ch5-BIB29|cit29","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2307\/4593651","article-title":"Benefits due to immunization against measles","volume":"84","author":"Axnick","year":"1969","journal-title":"Public Health Rep"},{"key":"10.1002\/9780470720912.ch5-BIB30|cit30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/jama.1981.03310300027014","article-title":"A cost-benefit analysis of immunization for pneumococcal pneumonia","volume":"245","author":"Patrick","year":"1981","journal-title":"JAMA (J Am Med Assoc)"}],"container-title":["Novartis Foundation Symposia","Ciba Foundation Symposium 110 - The Vaule of Preventive Medicine"],"original-title":[],"link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/9780470720912.ch5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:46:45Z","timestamp":1625014005000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/9780470720912.ch5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,30]]},"references-count":29,"URL":"https:\/\/doi.org\/10.1002\/9780470720912.ch5","relation":{},"ISSN":["1935-4657"],"issn-type":[{"value":"1935-4657","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,30]]}}}